-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Cephalotaxine
Category | Influenza Virus |
CAS | 24316-19-6 |
Description | Antiviral and antitumor agent. |
Product Information
Synonyms | (-)-Cephalotaxine; ZINC19795976 |
IUPAC Name | (2S,3S,6R)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.02,6.06,10.015,19]icosa-1(20),4,13,15(19)-tetraen-3-ol |
Molecular Weight | 315.36 |
Molecular Formula | C18H21NO4 |
Canonical SMILES | COC1=CC23CCCN2CCC4=CC5=C(C=C4C3C1O)OCO5 |
InChI | InChI=1S/C18H21NO4/c1-21-15-9-18-4-2-5-19(18)6-3-11-7-13-14(23-10-22-13)8-12(11)16(18)17(15)20/h7-9,16-17,20H,2-6,10H2,1H3/t16-,17-,18+/m1/s1 |
InChIKey | YMNCVRSYJBNGLD-KURKYZTESA-N |
Boiling Point | 495.2±45.0 °C at 760 mmHg |
Flash Point | 253.3±28.7 °C |
Purity | >98% |
Density | 1.4±0.1 g/cm3 |
Solubility | In Vitro: DMSO : 25 mg/mL(79.27 mM;Need ultrasonic) In Vivo: 1.Add each solvent one by one:10% DMSO >> 40%PEG300 >> 5%Tween-80 >> 45% saline Solubility: ≥ 2.5 mg/mL (7.93 mM); Clear solution 2.Add each solvent one by one:10% DMSO >> 90% (20%SBE-β-CDin saline) Solubility: ≥ 2.5 mg/mL (7.93 mM); Clear solution 3.Add each solvent one by one:10% DMSO >> 90%corn oil Solubility: ≥ 2.5 mg/mL (7.93 mM); Clear solution |
Appearance | Powder |
Application | antiviral; antitumor |
Storage | Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month |
Complexity | 523 |
Exact Mass | 315.14705815 |
Index Of Refraction | 1.665 |
In Vitro | Cephalotaxine inhibits Zika infection by impeding viral replication and stability. |
PSA | 51.16000 |
Target | Influenza Virus: ZIKV |
Vapor Pressure | 0.0±1.3 mmHg at 25°C |
XLogP3-AA | 0.2 |